Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work. [electronic resource]
Producer: 20171019Description: 126-135 p. digitalISSN:- 1558-822X
- Clinical Trials as Topic
- Combined Modality Therapy
- Graft vs Host Disease -- etiology
- Graft vs Tumor Effect -- immunology
- Hematopoietic Stem Cell Transplantation -- adverse effects
- Humans
- Killer Cells, Natural -- immunology
- Maintenance Chemotherapy
- Multiple Myeloma -- diagnosis
- Neoplasm, Residual -- pathology
- Receptors, KIR -- metabolism
- Retreatment
- Tissue Donors
- Transplantation Conditioning -- adverse effects
- Transplantation, Autologous
- Transplantation, Homologous
- Transplantation, Isogeneic
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.